Regulators Clear $50M Sale of Eli Lilly and Company Facility
Published: Aug 26, 2008
WASHINGTON -Federal antitrust regulators on Tuesday cleared Eli Lilly & Co.'s $50 million sale of a research facility to drug development services provider Covance Inc.